12/29/2020
3:20 PM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
12/29/2020
3:11 PM | Cellular Biomedicine Group (Filer)
| Form DEFM14A
| |
12/08/2020
5:52 AM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
12/08/2020
5:41 AM | Cellular Biomedicine Group (Filer)
| Form PRER14A
| |
12/04/2020
6:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2020
3:14 PM | Cellular Biomedicine Group (Subject)
| Form SC 13E3/A
| |
11/17/2020
3:11 PM | Cellular Biomedicine Group (Filer)
| Form PRER14A
| |
10/26/2020
6:04 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2020
6:16 AM | Cellular Biomedicine Group (Subject)
| Form SC 13E3
| |
10/09/2020
5:42 AM | Cellular Biomedicine Group (Filer)
| Form PREM14A
| |
|
08/28/2020
6:32 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2020
3:32 PM | Cellular Biomedicine Group (Issuer)
NOVARTIS AG (Reporting)
NOVARTIS PHARMA AG (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2020
3:17 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2020
10:16 AM | Cellular Biomedicine Group (Subject)
Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
08/12/2020
7:51 AM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D/A
| |
08/12/2020
6:02 AM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
08/12/2020
5:56 AM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
08/12/2020
5:54 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
3:15 PM | Cellular Biomedicine Group (Filer)
| Form NT 10-Q
| |
07/13/2020
6:32 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2020
8:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2020
3:38 PM | Cellular Biomedicine Group (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D/A
| |
06/24/2020
3:35 PM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D/A
| |
06/22/2020
8:15 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2020
5:07 AM | Cellular Biomedicine Group (Filer)
| Form DEFR14A
| |
04/29/2020
4:19 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
04/29/2020
4:19 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
04/01/2020
8:39 AM | Cellular Biomedicine Group (Subject)
Sailing Capital Overseas Investments Fund, LP (Filed by)
| Form SC 13D/A
| |
04/01/2020
8:37 AM | Cellular Biomedicine Group (Subject)
TF Venture Capital Management Co., Ltd. (Filed by)
| Form SC 13D/A
| |
04/01/2020
8:33 AM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D/A
| |
03/31/2020
9:16 AM | Cellular Biomedicine Group (Subject)
Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
02/24/2020
12:50 PM | Cellular Biomedicine Group (Subject)
Dangdai International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
02/24/2020
7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2020
3:05 PM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D/A
| |
02/13/2020
4:23 PM | Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/13/2020
4:20 PM | Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/03/2020
7:07 PM | Cellular Biomedicine Group (Issuer)
Chiang Chen Hsiu-Lien (Reporting)
TF Venture Capital Management Co., Ltd. (Reporting)
Winsor Capital Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2020
9:19 AM | Cellular Biomedicine Group (Subject)
TF Venture Capital Management Co., Ltd. (Filed by)
| Form SC 13D
| |
01/30/2020
8:18 AM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D/A
| |
01/30/2020
8:17 AM | Cellular Biomedicine Group (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D/A
| |
01/29/2020
4:00 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2019
7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2019
5:02 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2019
8:56 PM | Cellular Biomedicine Group (Issuer)
Zhang Li Helen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2019
8:53 PM | Cellular Biomedicine Group (Issuer)
Dai Chengxiang (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2019
8:50 PM | Cellular Biomedicine Group (Issuer)
HILLHOUSE CAPITAL ADVISORS, LTD. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2019
8:56 PM | Cellular Biomedicine Group (Issuer)
Mission Right Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2019
10:55 AM | Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
11/13/2019
9:07 AM | Cellular Biomedicine Group (Subject)
Liu Tony (Filed by)
| Form SC 13D
| |
11/12/2019
8:59 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
7:00 AM | Cellular Biomedicine Group (Subject)
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by)
| Form SC 13D
| |
11/08/2019
6:27 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
3:25 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2019
3:10 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
3:12 PM | Cellular Biomedicine Group (Issuer)
Schafer Edward T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2019
3:11 PM | Cellular Biomedicine Group (Issuer)
Schafer Edward T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/03/2019
7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2019
3:15 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2019
4:01 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
09/12/2019
6:49 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2019
2:24 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2019
3:10 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
3:03 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2019
8:07 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2019
11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
07/05/2019
3:12 PM | Cellular Biomedicine Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/03/2019
4:09 PM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
07/01/2019
4:25 PM | Cellular Biomedicine Group (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/17/2019
7:23 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2019
4:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019
8:27 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2019
8:44 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2019
8:24 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2019
10:33 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2019
8:31 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/22/2019
4:29 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
3:20 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
3:11 PM | Cellular Biomedicine Group (Filer)
| Form 424B5
| |
03/15/2019
4:13 PM | Cellular Biomedicine Group (Filer)
| Form DEFA14A
| |
03/15/2019
4:11 PM | Cellular Biomedicine Group (Filer)
| Form DEF 14A
| |
03/01/2019
10:05 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
4:01 PM | Cellular Biomedicine Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2019
8:53 PM | Cellular Biomedicine Group (Issuer)
Chan Andrew K (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/14/2019
8:50 PM | Cellular Biomedicine Group (Issuer)
Liu Tony (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/14/2019
8:48 PM | Cellular Biomedicine Group (Issuer)
Yao Yihong (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/25/2019
3:45 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2019
5:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2019
7:00 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2018
3:11 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
1:10 PM | Cellular Biomedicine Group (Subject)
Dangdal International Group Co. Ltd (Filed by)
| Form SC 13D/A
| |
11/06/2018
5:26 AM | Cellular Biomedicine Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2018
7:07 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2018
8:16 AM | Cellular Biomedicine Group (Filer)
| Form 424B3
| |
10/22/2018
11:15 PM | Cellular Biomedicine Group (Filer)
| Form EFFECT
| |
10/18/2018
3:13 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/18/2018
3:06 PM | Cellular Biomedicine Group (Filer)
| Form CT ORDER
| |
10/10/2018
6:11 PM | Cellular Biomedicine Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/10/2018
7:30 AM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
4:27 PM | Cellular Biomedicine Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
